Literature DB >> 17003305

Brain aging in very old men with type 2 diabetes: the Honolulu-Asia Aging Study.

Esther S C Korf1, Lon R White, Ph Scheltens, Lenore J Launer.   

Abstract

OBJECTIVE: Type 2 diabetes leads to cognitive impairment and dementia, which may reflect microvascular and macrovascular complications as well as neurodegenerative processes. There are few studies on the anatomical basis for loss of cognitive function in type 2 diabetes. The objective of this study was to investigate the association between type 2 diabetes and markers of brain aging on magnetic resonance images, including infarcts, lacunes, and white matter hyperintensities as markers of vascular damage and general and hippocampal atrophy as markers of neurodegeneration in Japanese-American men born between 1900 and 1919 and followed since 1965 in the Honolulu-Asia Aging Study. RESEARCH DESIGN AND METHODS: Prevalent and incident dementia was assessed. Associations between magnetic resonance imaging markers and diabetic status were estimated with logistic regression, controlling for sociodemographic and other vascular factors.
RESULTS: The prevalence of type 2 diabetes in the cohort is 38%. Subjects with type 2 diabetes had a moderately elevated risk for lacunes (odds ratio [OR] 1.6 [95% CI 1.0-2.6]) and hippocampal atrophy (1.7 [0.9-2.9]). The risk for both hippocampal atrophy and lacunes/infarcts was twice as high in subjects with compared with those without type 2 diabetes. Among the group with type 2 diabetes, those with the longest duration of diabetes, those taking insulin, and those with complications had relatively more pathologic brain changes.
CONCLUSIONS: There is evidence that older individuals with type 2 diabetes have an elevated risk for vascular brain damage and neurodegenerative changes. These pathological changes may be the anatomical basis for an increased risk of cognitive impairment or dementia in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003305     DOI: 10.2337/dc06-0243

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  64 in total

1.  Ventral striatal volume is associated with cognitive decline in older people: a population based MR-study.

Authors:  L W de Jong; Y Wang; L R White; B Yu; M A van Buchem; L J Launer
Journal:  Neurobiol Aging       Date:  2010-11-13       Impact factor: 4.673

2.  Different susceptibility of medial temporal lobe and basal ganglia atrophy rates to vascular risk factors.

Authors:  Laura W de Jong; Lars E Forsberg; Jean-Sébastien Vidal; Sigurdur Sigurdsson; Alex P Zijdenbos; Melissa Garcia; Gudny Eiriksdottir; Vilmundur Gudnason; Mark A van Buchem; Lenore J Launer
Journal:  Neurobiol Aging       Date:  2013-08-28       Impact factor: 4.673

Review 3.  The relationship between blood pressure and cognitive function.

Authors:  Vera Novak; Ihab Hajjar
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

Review 4.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

5.  The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: The DHS-Mind study.

Authors:  Christina E Hugenschmidt; Fang-Chi Hsu; Satoru Hayasaka; J Jeffrey Carr; Barry I Freedman; David L Nyenhuis; Jeff D Williamson; Donald W Bowden
Journal:  J Diabetes Complications       Date:  2013-05-07       Impact factor: 2.852

Review 6.  Vascular risk factors: imaging and neuropathologic correlates.

Authors:  David S Knopman; Rosebud Roberts
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Relationships between diabetes and cognitive impairment.

Authors:  Suzanne M de la Monte
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

8.  Anemia is associated with the progression of white matter disease in older adults with high blood pressure: the cardiovascular health study.

Authors:  Marco Inzitari; Stephanie Studenski; Caterina Rosano; Neil A Zakai; William T Longstreth; Mary Cushman; Anne B Newman
Journal:  J Am Geriatr Soc       Date:  2008-09-22       Impact factor: 5.562

9.  Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes.

Authors:  Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

10.  Accelerated progression from mild cognitive impairment to dementia in people with diabetes.

Authors:  Weili Xu; Barbara Caracciolo; Hui-Xin Wang; Bengt Winblad; Lars Bäckman; Chengxuan Qiu; Laura Fratiglioni
Journal:  Diabetes       Date:  2010-08-16       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.